Recalls

All US Product Recalls

Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.

How to read this listing

Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means deaths or serious injuries are reported, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.

The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.

Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.

Agency

All agencies FDA (Food)FDA (Drugs)FDA (Devices)USDA FSIS CPSC NHTSA EPA

1326–1350 of 3644

CriticalFDA (Drugs)·D-0459-2024·2024-05-01
FDA Recalls Alcoholada Gel Pain Reliever Over Methanol Contamination
Alcoholada Gel pain reliever is being recalled because the ethanol ingredient contains methanol contamination. The FDA classified this as a Class I recall affecting 9,625 bottles distributed nationwide.
Product
Alcoholada Gel, Pain Relieving Gel, 0.5% Lidocaine Hydrochloride, packaged in (a) 8.5 fl oz (251 mL) plastic bottle UPC 0 82252 03120 9 (b) 2.2 fl oz (65 mL) plastic bottle, UPC 0 82252 34030 1 , Manufactured in Aruba by Aruba Aloe Balm Inc., Pitastraat 115, Aruba, Dutch Caribbe
Category
Drug
Distribution
Distributed nationwide
CriticalFDA (Drugs)·D-0455-2024·2024-05-01
Silverback XXX Power male enhancement product recalled for undeclared sildenafil and tadalafil
Pyramids Wholesale Inc. is recalling Silverback XXX Power male enhancement nationwide due to undeclared sildenafil and/or tadalafil. These prescription drugs were not approved by the FDA before marketing.
Product
SILVERBACK XXX POWER MALE ENHANCEMENT, 2 fl. oz., UPC 8 700470 032762
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0450-2024·2024-05-01
FDA Recalls Flower Power Female Enhancement for Undeclared Sildenafil and Tadalafil
Flower Power CBD infused Female Enhancement contains undeclared sildenafil and tadalafil. These prescription drugs were not disclosed to consumers and the product was marketed without FDA approval.
Product
Flower Power, CBD infused Female Enhancement, 59 ml bottle, UPC 0 678741 351646.
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0457-2024·2024-05-01
Male Performance Enhancer Recalled for Undeclared Sildenafil and Tadalafil
ALPHASTRIP Male Performance Enhancer strips are being recalled nationwide because they contain undeclared sildenafil and tadalafil. The product was marketed without FDA approval.
Product
ALPHASTRIP MALE PERFORMANCE ENHANCER, The fastest acting sublingual, Serving Size (1 strip), Distributed by: GALT INT'L
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0451-2024·2024-05-01
Samurai-X Honey 6800 Recalled for Undeclared Drug Ingredients
Samurai-X Honey 6800, manufactured by Pyramids Wholesale Inc., is recalled for containing undeclared sildenafil and/or tadalafil. The product was distributed nationwide and marketed without FDA drug approval.
Product
Samurai-X Honey 6800, UPC 2 56891 27553 3.
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0452-2024·2024-05-01
Pink Pussycat Honey recalled for undeclared sildenafil and tadalafil content
Pyramids Wholesale Inc. is recalling Pink Pussycat Honey because it contains undeclared sildenafil and tadalafil and was marketed without FDA approval. The recall affects all lots nationwide.
Product
Pink Pussycat Honey, net wt: 20gx12 sachets, UPC 7 918750 046557
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0458-2024·2024-05-01
Sexual Enhancement Product Recalled for Undeclared Prescription Drugs
Pyramids Wholesale Inc. is recalling HONEY MANUKA BUNNY LOVE nationwide because it contains undeclared sildenafil and/or tadalafil—prescription medications—and was marketed without FDA approval.
Product
HONEY MANUKA BUNNY LOVE, 12g, All Natural Sexual Enhancement, UPC: N/A
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0470-2024·2024-05-01
ForeverMen Natural Energy Boost Capsules Recalled for Undeclared Sildenafil
ForeverMen Natural Energy Boost Capsules contain undeclared sildenafil and are marketed without FDA approval, making them an unapproved drug. Consumers should stop using the product immediately.
Product
ForeverMen Natural Energy Boost Capsules, packaged in a box containing a 10-count blister card.
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0449-2024·2024-05-01
Honey product recalled nationwide for undeclared sildenafil and tadalafil
Pyramids Wholesale Inc. is recalling Weiner Boner Honey due to undeclared sildenafil and tadalafil. The product was distributed nationwide without FDA approval.
Product
Weiner Boner Honey, 12g packet, 100% Organic Formula.
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0454-2024·2024-05-01
FDA Recalls libigrow RED DRAGON+ Capsules for Undeclared Sildenafil and Tadalafil
Pyramids Wholesale Inc. is recalling libigrow RED DRAGON+ capsules nationwide because they contain undeclared sildenafil and tadalafil, prescription medications not approved by the FDA for this product.
Product
libigrow RED DRAGON+, Maximum Strength Formula, 2 capsules per box, UPC 7 05105 83073 5.
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0456-2024·2024-05-01
The GOAT Sublingual Strip Recalled for Undeclared Prescription Drug Ingredients
The GOAT Sublingual Strip male enhancement product, distributed nationwide, was recalled for containing undeclared sildenafil and tadalafil. The product was marketed without FDA approval.
Product
The GOAT SUBLINGUAL STRIP, MALE ENHANCEMENT, 2 Pack, Distributed by Hombres LLC, 130 Maccormick Ave, Suite 105, Costa Mesa, A, UPC 6 61631 26363 1.
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0453-2024·2024-05-01
Male Sexual Enhancement Product Recalled for Undeclared Pharmaceutical Ingredients
Pyramids Wholesale Inc. is recalling all lots of GoHARD 25000 because it contains undeclared sildenafil and tadalafil. The product was marketed without FDA approval for these prescription-strength drugs.
Product
GoHARD 25000, Male Sexual Enhancement, Honey, 100% Natural, UPC: N/A.
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0460-2024·2024-05-01
FDA Recalls Aruba Aloe Hand Sanitizer for Methanol Contamination
FDA is recalling 5,299 bottles of Aruba Aloe Hand Sanitizer Gel nationwide due to methanol contamination in the ethanol ingredient. Consumers should stop using the product immediately.
Product
Aruba Aloe Hand Sanitizer Gel, 80% Alcohol, 12 fl oz (355 mL) plastic bottle, Manufactured in Aruba by Aruba Aloe Balm Inc., Pitastraat 115, Aruba, Dutch Caribbean. UPC 0 82252 03300 5
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0448-2024·2024-05-01
Spanish Fly 22K Capsules Recalled for Undeclared Prescription Drug Ingredients
Spanish Fly 22K capsules contain undeclared sildenafil and/or tadalafil and were marketed without FDA approval. The product poses serious health risks from these unapproved pharmaceutical ingredients.
Product
Spanish Fly 22K capsules, 2-count box, UPC 0 664979 979455
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-0475-2024·2024-05-01
Minolira extended-release tablets recalled due to discontinued quality assurance program
EPI Health is recalling 5,664 bottles of minolira tablets because the manufacturer discontinued its quality assurance program. Affected lots include T2201700 and T2201701, distributed nationwide.
Product
minolira (minocycline hydrochloride) extended-release tablets, 135mg 30-count Bottle, Rx Only, Mfg by: Dr Reddy's Laboratories Limited, INDIA, Manufactured for: EPI Health, LLC, Charleston, SC 29403, NDC 71403-102-30.
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-0472-2024·2024-05-01
Prescription Drug Recall: Diltiazem Extended-Release Capsules Fail Dissolution Test
Glenmark Pharmaceuticals is recalling 3,264 bottles of Diltiazem Hydrochloride Extended-Release Capsules nationwide due to failure to meet dissolution specifications. The affected lot may not release the medication properly in the body.
Product
DILTIAZEM HYDROCHLORIDE — DILTIAZEM HYDROCHLORIDE (DILTIAZEM HYDROCHLORIDE)
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-0463-2024·2024-05-01
GloStrips ophthalmic drug recalled for active ingredient impurities
Nomax Inc is recalling GloStrips fluorescein sodium ophthalmic strips nationwide due to failure of the active pharmaceutical ingredient to meet USP standards for unspecified impurities.
Product
GLOSTRIPS — GLOSTRIPS (FLUORESCEIN SODIUM)
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-0473-2024·2024-05-01
Cloderm Cream Recalled for Manufacturer Quality Assurance Program Discontinuation
EPI Health is recalling Cloderm cream due to discontinuation of the manufacturer's quality assurance program. This may result in products that do not meet specifications for identity, strength, purity, or quality.
Product
Cloderm (clocortolone pivalate) Cream, 0.1%, Rx Only, For Topical Use Only, Net Wt 45g, Manufactured for: EPI Health, LLC, Charleston, SC 29403, NDC 71403-804-90
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-0462-2024·2024-05-01
Ophthalmic Drug GloStrips Recalled for Active Ingredient Impurities
FDA recalls GloStrips (Fluorescein Sodium) ophthalmic strips due to manufacturing defects in the active pharmaceutical ingredient. The API does not meet current USP purity standards for unspecified impurities.
Product
GLOSTRIPS — GLOSTRIPS (FLUORESCEIN SODIUM)
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-0464-2024·2024-05-01
FDA Recalls Fluorescein Sodium Ophthalmic Strips for Manufacturing Defect
The FDA is recalling FUL-GLO Fluorescein Sodium Sterile Ophthalmic Strips (4,648 cartons) nationwide due to unspecified impurities in the active ingredient exceeding USP standards.
Product
FUL-GLO, Fluorescein Sodium Sterile Ophthalmic Strips USP (0.6 mg Fluorescein), 300 sterile strips per carton, Manufactured for: Akorn, Inc., Lake Forest, IL 60045, NDC 17478-403-03.
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-0474-2024·2024-05-01
Minocycline Extended-Release Tablets Recalled for Manufacturing Quality Control Failure
EPI Health is recalling minolira extended-release tablets due to manufacturer discontinuation of quality control programs affecting product identity, strength, and purity. The recall covers 12,808 bottles distributed nationwide.
Product
minolira (minocycline hydrochloride) extended-release tablets, 105mg 30-count Bottle, Rx Only, Mfg by: Dr Reddy's Laboratories Limited, INDIA, Manufactured for: EPI Health, LLC, Charleston, SC 29403, NDC 71403-101-30.
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-0471-2024·2024-05-01
Prescription respiratory drug recalled for short fill in unit-dose vials
Cipla USA recalls Ipratropium Bromide and Albuterol Sulfate inhalation solution due to short fill in unit-dose vials. Some vials contain less medication than labeled, affecting dosage.
Product
IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE — IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE (IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE)
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0444-2024·2024-04-24
Atovaquone Oral Suspension Recalled Due to Potential Bacillus Contamination
AvKARE recalls Atovaquone Oral Suspension due to potential Bacillus cereus contamination of a non-sterile product. The recalled lot (AW0221A, Exp. 08/30/2025) was distributed nationwide; 153 cartons affected.
Product
Atovaquone Oral Suspension USP, 750 mg per 5 mL sachets, 20 Units x 5 mL cartons, Rx Only, Manufactured for: AvKARE, Pulaski, TN 38478, NDC 50268-086-12.
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Food)·F-1172-2024·2024-04-24
Brazil seed dietary supplement recalled for yellow oleander contamination
HandNatural's H&Natural Brazil Seed dietary supplement is being recalled due to the presence of yellow oleander, a toxic plant component. Distribution was exclusively through internet sales.
Product
H&NATURAL BRAZIL SEED 30 PIECES, PURE NATURAL SEMILLA DE BRASIL FOR 30 DAYS, 5 GRAMS PER BOX, ORANGE BOTTLE.
Category
Drug
Distribution
0 states
SevereFDA (Drugs)·D-0442-2024·2024-04-24
Vancomycin Hydrochloride Oral Solution Recalled Nationwide for Superpotency Due to Overfilling
Amneal Pharmaceuticals is recalling Vancomycin Hydrochloride Oral Solution nationwide due to manufacturing overfilling causing superpotency with higher-than-labeled concentration. The FDA classified this as Class I.
Product
VANCOMYCIN HYDROCHLORIDE — VANCOMYCIN HYDROCHLORIDE (VANCOMYCIN HYDROCHLORIDE)
Category
Drug
Distribution
Distributed nationwide

How to read this listing

Filters

1326–1350 of 3644